QNTM Quantum Biopharma Ltd.
$2.32▲ +4.98%
Healthcare
Other
Volume 86.8K
Avg Volume (10D) 113.5K
Key Metrics & Fundamentals
Market Cap
$14.92M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.07 - 13.88
% vs 50 MA
-27.04%
% vs 200 MA
-41.29%
RSI-14
30.9
MACD Histogram
-0.0500
Beta (1Y vs SPY)
0.58
Free Cash Flow
-$1.79M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.12M
COGS
–
Operating Exp
$2.28M
Operating Income
-$2.28M
EBIT
-$2.28M
Pretax Income
-$3.09M
Net Income
-$3.25M
EPS (Diluted)
-0.47
Price & Volume History
Loading chart…
Recent News
Quantum BioPharma (QNTM) Featured in Men's Fitness Article Examining Unbuzzd Clinical Trial Results
NewMediaWire · Oct 20, 2026 2:30 PM ET
Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
MarketBeat · Oct 14, 2026 9:50 AM ET
Why Thermo Fisher Scientific (TMO) Is Back In The Spotlight
Simply Wall St. · Oct 8, 2026 10:08 AM ET
World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
GlobeNewswire · Oct 8, 2026 8:00 AM ET
Quantum BioPharma (QNTM) Enlists Thermo Fisher's Clinical Research Business to Launch Phase 2 Lucid-MS Trial
NewMediaWire · Oct 7, 2026 3:30 PM ET
Quantum BioPharma (QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
NewMediaWire · Oct 6, 2026 3:00 PM ET
Quantum BioPharma, Thermo Fisher Partner on Phase 2 Multiple Sclerosis Trial
MT Newswires · Oct 6, 2026 6:44 AM ET
Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis
GlobeNewswire · Oct 6, 2026 6:00 AM ET
EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial
Benzinga · Oct 6, 2026 5:48 AM ET
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
GlobeNewswire · Sep 30, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See QNTM's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.